Orchestra BioMed Holdings Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Orchestra BioMed Holdings Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- OBIO
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001814114
Board of directors
-
Chris Cleary · DirectorSince 2025
-
Connealy Pamela Yanchik · DirectorSince 2023
-
Darren Sherman · Director · See RemarksSince 2023
-
David P. Hochman · Director · See RemarksSince 2023
-
David Pacitti · DirectorSince 2024
-
Eric A. Rose M.D. · DirectorSince 2023
-
Eric S. Fain · DirectorSince 2023
-
Geoffrey Wade Smith · DirectorSince 2023
-
Jason Aryeh · DirectorSince 2023
-
John Prosper Mack · DirectorSince 2024
-
Roderick Wong · Director · Chief Executive OfficerSince 2023
-
Yuval Mika · Director · See RemarksSince 2023
Chief executives
Roderick Wong
· Chief Executive Officer
Dates unknown
Board connections
2 of this board's directors also sit on 3 other boards.
- via Jason Aryeh
- via Jason Aryeh
- via Roderick Wong
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $63,250
- 2 purchases by 1 insider
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 25, 2026 | Darren Sherman Director, Officer (See Remarks) | Shares withheld for tax | −33,317 | $4.57 | $152,259 |
| Mar 25, 2026 | Aiello Joshua Officer (Principal Accounting Officer) | Shares withheld for tax | −241 | $4.57 | $1,101 |
| Mar 25, 2026 | David P. Hochman Director, Officer (See Remarks) | Shares withheld for tax | −32,438 | $4.57 | $148,242 |
| Mar 13, 2026 | David P. Hochman Director, Officer (See Remarks) | Open-market purchase | +10,000 | $4.29 | $42,900 |
| Dec 10, 2025 | Taylor Andrew Lawrence Officer (Chief Financial Officer) | Shares withheld for tax | −8,670 | $4.67 | $40,489 |
| Dec 10, 2025 | David P. Hochman Director, Officer (See Remarks) | Shares withheld for tax | −40,355 | $4.67 | $188,458 |
| Dec 10, 2025 | David P. Hochman Director, Officer (See Remarks) | Shares withheld for tax | −3,283 | $4.67 | $15,332 |
| Nov 25, 2025 | Taylor Andrew Lawrence Officer (Chief Financial Officer) | Shares withheld for tax | −3,071 | $5.35 | $16,430 |
| Nov 25, 2025 | Darren Sherman Director, Officer (See Remarks) | Shares withheld for tax | −40,340 | $5.35 | $215,819 |
| Nov 14, 2025 | David P. Hochman Director, Officer (See Remarks) | Open-market purchase | +5,000 | $4.07 | $20,350 |
| Nov 13, 2025 | David P. Hochman Director, Officer (See Remarks) | Shares withheld for tax | −3,283 | $4.18 | $13,723 |
| Nov 13, 2025 | David P. Hochman Director, Officer (See Remarks) | Shares withheld for tax | −3,283 | $4.18 | $13,723 |
| Sep 19, 2025 | Jason Aryeh Director | Open-market purchase | +1,000 | $2.45 | $2,450 |
| Sep 17, 2025 | Aiello Joshua Officer (Principal Accounting Officer) | Shares withheld for tax | −203 | $2.46 | $499 |
| Sep 17, 2025 | Taylor Andrew Lawrence Officer (Chief Financial Officer) | Shares withheld for tax | −16,102 | $2.46 | $39,611 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.